BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 12873891)

  • 21. Mycosis fungoides and the Sézary syndrome.
    Kim YH; Hoppe RT
    Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous presentations of lymphoma in human immunodeficiency virus disease. Predominance of T cell lineage.
    Kerschmann RL; Berger TG; Weiss LM; Herndier BG; Abrahms KM; Heon V; Schulze K; Kaplan LD; Resnik SD; LeBoit PE
    Arch Dermatol; 1995 Nov; 131(11):1281-8. PubMed ID: 7503572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypopigmented mycosis fungoides in children: a clinicopathological study of 6 cases].
    Wang T; Liu YH; Zheng HY; Sun QN; Jin HZ; Li F; Fang K; Yan Y
    Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(46):3287-90. PubMed ID: 21223789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycosis fungoides palmaris et plantaris--an unusual variant of cutaneous T-cell lymphoma.
    Topf S; Lüftl M; Neisius U; Brabletz T; Simon M; Schuler G; Schultz ES
    Eur J Dermatol; 2006; 16(1):84-6. PubMed ID: 16436350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.
    Hughes CF; Newland K; McCormack C; Lade S; Prince HM
    Australas J Dermatol; 2016 Aug; 57(3):182-91. PubMed ID: 25988337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous T-cell lymphomas: a review with emphasis on new treatment approaches.
    Querfeld C; Rosen ST; Kuzel TM; Guitart J
    Semin Cutan Med Surg; 2003 Sep; 22(3):150-61. PubMed ID: 14649582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.
    Olsen EA
    Dermatol Clin; 2015 Oct; 33(4):643-54. PubMed ID: 26433839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous T-cell lymphoma-Focus on some problems, and some solutions.
    Beltraminelli H
    Hematol Oncol; 2023 Jun; 41 Suppl 1():20-24. PubMed ID: 37294972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cutaneous T-cell lymphoma].
    Dippel E; Gellrich S; Klemke CD; Goerdt S; Sterry W
    J Dtsch Dermatol Ges; 2003 Dec; 1(12):965-80; quiz 981-2. PubMed ID: 16285650
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnosis of malignant cutaneous lymphomas].
    Sterry W
    Dtsch Med Wochenschr; 1988 Feb; 113(5):184-9. PubMed ID: 3276493
    [No Abstract]   [Full Text] [Related]  

  • 31. [Epitheliotropic lymphomas: better identification for improved treatment].
    Bagot M
    Bull Acad Natl Med; 2010 Oct; 194(7):1365-72. PubMed ID: 22043631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment.
    Hoppe RT; Wood GS; Abel EA
    Curr Probl Cancer; 1990; 14(6):293-371. PubMed ID: 2245651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A modified staging classification for cutaneous T-cell lymphoma.
    Kashani-Sabet M; McMillan A; Zackheim HS
    J Am Acad Dermatol; 2001 Nov; 45(5):700-6. PubMed ID: 11606919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Microenvironment's Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic Implications.
    Pileri A; Guglielmo A; Grandi V; Violetti SA; Fanoni D; Fava P; Agostinelli C; Berti E; Quaglino P; Pimpinelli N
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group.
    Lamberg SI; Green SB; Byar DP; Block JB; Clendenning WE; Epstein EH; Fuks ZY; Golitz LE; Lorincz AL; Michel B; Roenigk HH; Van Scott EJ; Vonderheid EC; Thomas RJ
    Cancer Treat Rep; 1979 Apr; 63(4):701-7. PubMed ID: 376140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Not Available].
    Cedef
    Ann Dermatol Venereol; 2018 Mar; 145 Suppl 1():S186-S188. PubMed ID: 29475620
    [No Abstract]   [Full Text] [Related]  

  • 37. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.
    Trautinger F; Knobler R; Willemze R; Peris K; Stadler R; Laroche L; D'Incan M; Ranki A; Pimpinelli N; Ortiz-Romero P; Dummer R; Estrach T; Whittaker S
    Eur J Cancer; 2006 May; 42(8):1014-30. PubMed ID: 16574401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new nail in the CTCL coffin.
    Lessin SR
    J Invest Dermatol; 2006 Nov; 126(11):2368-9. PubMed ID: 17041618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.
    Olsen EA; Whittaker S; Willemze R; Pinter-Brown L; Foss F; Geskin L; Schwartz L; Horwitz S; Guitart J; Zic J; Kim YH; Wood GS; Duvic M; Ai W; Girardi M; Gru A; Guenova E; Hodak E; Hoppe R; Kempf W; Kim E; Lechowicz MJ; Ortiz-Romero P; Papadavid E; Quaglino P; Pittelkow M; Prince HM; Sanches JA; Sugaya M; Vermeer M; Zain J; Knobler R; Stadler R; Bagot M; Scarisbrick J
    Blood; 2022 Aug; 140(5):419-437. PubMed ID: 34758074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous T-cell lymphoma.
    Gemmill R
    Semin Oncol Nurs; 2006 May; 22(2):90-6. PubMed ID: 16720231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.